Schizophrenia Journal
@schizjournal.bsky.social
Schizophrenia is a high-quality Springer Nature journal published in partnership with the Schizophrenia Research Society (SIRS) @SIRSGlobal
nature.com/npjschz/
nature.com/npjschz/
Reposted by Schizophrenia Journal
🏛 SIRS 2026 Elections – Nominations Open!
We’re accepting nominations for:
✨ President-Elect
✨ Board Members (6 positions)
✨ Junior Board Members (3 positions)
Help shape the Society’s future.
🗓 Deadline: 28 November 2025
🔗: sirs.societyconference.com?conf_id=1002...
#SIRS2026
We’re accepting nominations for:
✨ President-Elect
✨ Board Members (6 positions)
✨ Junior Board Members (3 positions)
Help shape the Society’s future.
🗓 Deadline: 28 November 2025
🔗: sirs.societyconference.com?conf_id=1002...
#SIRS2026
November 12, 2025 at 4:03 PM
🏛 SIRS 2026 Elections – Nominations Open!
We’re accepting nominations for:
✨ President-Elect
✨ Board Members (6 positions)
✨ Junior Board Members (3 positions)
Help shape the Society’s future.
🗓 Deadline: 28 November 2025
🔗: sirs.societyconference.com?conf_id=1002...
#SIRS2026
We’re accepting nominations for:
✨ President-Elect
✨ Board Members (6 positions)
✨ Junior Board Members (3 positions)
Help shape the Society’s future.
🗓 Deadline: 28 November 2025
🔗: sirs.societyconference.com?conf_id=1002...
#SIRS2026
👉New Article Collection!
We are proud to highlight our new article collection, Pathways to prevention: background and methodology for the Accelerating Medicines Partnership® Schizophrenia Program
@sirsofficial.bsky.social go.nature.com/495Z3Av
We are proud to highlight our new article collection, Pathways to prevention: background and methodology for the Accelerating Medicines Partnership® Schizophrenia Program
@sirsofficial.bsky.social go.nature.com/495Z3Av
Pathways to prevention: background and methodology for the Accelerating Medicines Partnership® Schizophrenia Program
The discovery of antipsychotic drugs for the treatment of schizophrenia has reshaped the landscape for the ability to treat this devastating disorder. ...
go.nature.com
November 9, 2025 at 3:38 PM
👉New Article Collection!
We are proud to highlight our new article collection, Pathways to prevention: background and methodology for the Accelerating Medicines Partnership® Schizophrenia Program
@sirsofficial.bsky.social go.nature.com/495Z3Av
We are proud to highlight our new article collection, Pathways to prevention: background and methodology for the Accelerating Medicines Partnership® Schizophrenia Program
@sirsofficial.bsky.social go.nature.com/495Z3Av
Reposted by Schizophrenia Journal
Schizophrenia isn’t just in the brain. 🧠💔🦴
New study (Xie et al., 2025, Schizophrenia) maps shared genetic links between SCZ and heart, bone & abdominal organ imaging traits—revealing its truly systemic nature and new therapeutic targets.
🔗 www.nature.com/articles/s41...
New study (Xie et al., 2025, Schizophrenia) maps shared genetic links between SCZ and heart, bone & abdominal organ imaging traits—revealing its truly systemic nature and new therapeutic targets.
🔗 www.nature.com/articles/s41...
October 15, 2025 at 11:01 AM
Schizophrenia isn’t just in the brain. 🧠💔🦴
New study (Xie et al., 2025, Schizophrenia) maps shared genetic links between SCZ and heart, bone & abdominal organ imaging traits—revealing its truly systemic nature and new therapeutic targets.
🔗 www.nature.com/articles/s41...
New study (Xie et al., 2025, Schizophrenia) maps shared genetic links between SCZ and heart, bone & abdominal organ imaging traits—revealing its truly systemic nature and new therapeutic targets.
🔗 www.nature.com/articles/s41...
Reposted by Schizophrenia Journal
New research explores how childhood trauma and violence intersect in schizophrenia. Reduced connectivity between the orbitofrontal & temporal brain regions mediates this link—potential neural targets for trauma-related interventions.
🔗 www.nature.com/articles/s41...
🔗 www.nature.com/articles/s41...
October 24, 2025 at 2:31 PM
New research explores how childhood trauma and violence intersect in schizophrenia. Reduced connectivity between the orbitofrontal & temporal brain regions mediates this link—potential neural targets for trauma-related interventions.
🔗 www.nature.com/articles/s41...
🔗 www.nature.com/articles/s41...
Reposted by Schizophrenia Journal
In Clinical High Risk research, how participants are recruited matters. Recruitment sources influence sex, age, and clinical profiles, shaping the heterogeneity seen across CHR studies. Accounting for these differences is crucial when interpreting findings.
🔗 Article: www.nature.com/articles/s41...
🔗 Article: www.nature.com/articles/s41...
October 28, 2025 at 5:04 PM
In Clinical High Risk research, how participants are recruited matters. Recruitment sources influence sex, age, and clinical profiles, shaping the heterogeneity seen across CHR studies. Accounting for these differences is crucial when interpreting findings.
🔗 Article: www.nature.com/articles/s41...
🔗 Article: www.nature.com/articles/s41...
New review addressing the knowledge gap between voice hearing in psychosis and perceptual experiences in other sensory modalities with overview of voices and altered perceptual experiences across psychotic, mood and anxiety disorders @sirsofficial.bsky.social bit.ly/3J5ibDW
Hearing voices and other altered perceptual experiences across psychotic, mood, and anxiety disorders: from phenomenology and mechanisms to future directions - Schizophrenia
Schizophrenia - Hearing voices and other altered perceptual experiences across psychotic, mood, and anxiety disorders: from phenomenology and mechanisms to future directions
bit.ly
October 14, 2025 at 4:22 PM
New review addressing the knowledge gap between voice hearing in psychosis and perceptual experiences in other sensory modalities with overview of voices and altered perceptual experiences across psychotic, mood and anxiety disorders @sirsofficial.bsky.social bit.ly/3J5ibDW
A New Chapter for Schizophrenia Journal... 📖
📖 A New Chapter for Schizophrenia
Thank you to Dr. Robin Emsley for 3.5 years of leadership as Editor. Welcome Dr. Anthony A. Grace, Distinguished Professor and global leader in schizophrenia research, as our new Editor.
Please join us in celebrating this transition!💫
#SIRS #SchizophreniaResearch
Thank you to Dr. Robin Emsley for 3.5 years of leadership as Editor. Welcome Dr. Anthony A. Grace, Distinguished Professor and global leader in schizophrenia research, as our new Editor.
Please join us in celebrating this transition!💫
#SIRS #SchizophreniaResearch
October 3, 2025 at 10:46 AM
A New Chapter for Schizophrenia Journal... 📖
New investigation of what lies behind the 17-year reduction in life expectancy gap between #schizophrenia patients and the general population. 2nd-gen antipsychotics and low frequency hospitalization were associated with reduced mortality @sirsofficial.bsky.social bit.ly/4gdulqF
What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population? - Schizophrenia
Schizophrenia - What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population?
bit.ly
September 8, 2025 at 7:14 AM
New investigation of what lies behind the 17-year reduction in life expectancy gap between #schizophrenia patients and the general population. 2nd-gen antipsychotics and low frequency hospitalization were associated with reduced mortality @sirsofficial.bsky.social bit.ly/4gdulqF
Reposted by Schizophrenia Journal
💡 New Findings in Clozapine Pharmacokinetics
🔗 Read the study here: doi.org/10.1038/s415...
#Clozapine #Pharmacokinetics #Inflammation #Schizophrenia
🔗 Read the study here: doi.org/10.1038/s415...
#Clozapine #Pharmacokinetics #Inflammation #Schizophrenia
Elevated neutrophil-to-lymphocyte ratios correlate with increased clozapine concentration-to-dose ratios during titration - Schizophrenia
Schizophrenia - Elevated neutrophil-to-lymphocyte ratios correlate with increased clozapine concentration-to-dose ratios during titration
doi.org
July 15, 2025 at 2:44 PM
💡 New Findings in Clozapine Pharmacokinetics
🔗 Read the study here: doi.org/10.1038/s415...
#Clozapine #Pharmacokinetics #Inflammation #Schizophrenia
🔗 Read the study here: doi.org/10.1038/s415...
#Clozapine #Pharmacokinetics #Inflammation #Schizophrenia
Reposted by Schizophrenia Journal
📆 September is here! Your SIRS Submission Deadlines are Approaching FAST!
Be Part of the Conversation in Florence, Italy
Submit Your Symposia Proposal Today!
#SIRS2026
LINK: sirs.societyconference.com/v2/#card/sub...
Be Part of the Conversation in Florence, Italy
Submit Your Symposia Proposal Today!
#SIRS2026
LINK: sirs.societyconference.com/v2/#card/sub...
September 3, 2025 at 6:47 PM
📆 September is here! Your SIRS Submission Deadlines are Approaching FAST!
Be Part of the Conversation in Florence, Italy
Submit Your Symposia Proposal Today!
#SIRS2026
LINK: sirs.societyconference.com/v2/#card/sub...
Be Part of the Conversation in Florence, Italy
Submit Your Symposia Proposal Today!
#SIRS2026
LINK: sirs.societyconference.com/v2/#card/sub...
New study found longitudinal changes in striatocortical connectivity in first-episode psychosis associated with the emergence of treatment resistance. @sirsofficial.bsky.social bit.ly/3JHvj26
Longitudinal changes in striatocortical connectivity in first-episode psychosis associated with the emergence of treatment resistance - Schizophrenia
Schizophrenia - Longitudinal changes in striatocortical connectivity in first-episode psychosis associated with the emergence of treatment resistance
bit.ly
September 1, 2025 at 11:57 AM
New study found longitudinal changes in striatocortical connectivity in first-episode psychosis associated with the emergence of treatment resistance. @sirsofficial.bsky.social bit.ly/3JHvj26
How can smartphone and wearable digital biomarkers inform about risk of developing schizophrenia? Learn more about the use of digital phenotyping in the #AMP_SZ study in this new paper #biomarkers @SIRSGlobal bit.ly/4kxW1qH
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program - Schizophrenia
Schizophrenia - Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program
bit.ly
July 11, 2025 at 9:00 AM
How can smartphone and wearable digital biomarkers inform about risk of developing schizophrenia? Learn more about the use of digital phenotyping in the #AMP_SZ study in this new paper #biomarkers @SIRSGlobal bit.ly/4kxW1qH
Advances in proteomics & genomics are shedding light on biomarkers linked to schizophrenia risk. The AMP® Schizophrenia study is tracking 2,000+ participants to uncover blood & saliva markers that predict outcomes & reveal underlying biology. #Psychiatry #Biomarkers #AMP_SCZ bit.ly/3IB5Dn6
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations - Schizophrenia
Schizophrenia - Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations
bit.ly
July 10, 2025 at 9:21 AM
Advances in proteomics & genomics are shedding light on biomarkers linked to schizophrenia risk. The AMP® Schizophrenia study is tracking 2,000+ participants to uncover blood & saliva markers that predict outcomes & reveal underlying biology. #Psychiatry #Biomarkers #AMP_SCZ bit.ly/3IB5Dn6
🚨 AMP SCZ EEG Study! 🧠⚡ CHR patients need better treatments. EEG biomarkers show strong reliability & potential for predicting outcomes, tracking illness, & guiding interventions #EEG bit.ly/46ungiw
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures - Schizophrenia
Schizophrenia - The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures
bit.ly
July 9, 2025 at 9:13 AM
🚨 AMP SCZ EEG Study! 🧠⚡ CHR patients need better treatments. EEG biomarkers show strong reliability & potential for predicting outcomes, tracking illness, & guiding interventions #EEG bit.ly/46ungiw
Curious about predicting clinical outcomes? New paper in @schizjournal.bsky.social special issue shows how multidisciplinary experts shaped the AMP #Schizophrenia analysis strategy. Explore key decisions & data-driven insights! @sirsofficial.bsky.social @NoraPenzel @poloscience go.nature.com/4lYwQzv
Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program - Schizophrenia
Schizophrenia - Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program
go.nature.com
May 2, 2025 at 7:55 AM
Curious about predicting clinical outcomes? New paper in @schizjournal.bsky.social special issue shows how multidisciplinary experts shaped the AMP #Schizophrenia analysis strategy. Explore key decisions & data-driven insights! @sirsofficial.bsky.social @NoraPenzel @poloscience go.nature.com/4lYwQzv
Getting lived experience to guide psychosis research: The AMP® SCZ program integrates voices of those with lived experience into every stage to foster trust, enhance research outcomes, and inform future strategies for treatment and prevention @sirsofficial.bsky.social go.nature.com/4lIGYfu
Bridging Science and Hope: integrating and Communicating Lived experience in Accelerating Medicines Partnership® Schizophrenia Program - Schizophrenia
The Accelerating Medicines Partnership Schizophrenia (AMP® SCZ) program integrates lived experience into psychosis research, leveraging over three decades of foundational studies to improve research q...
go.nature.com
April 23, 2025 at 8:24 AM
Getting lived experience to guide psychosis research: The AMP® SCZ program integrates voices of those with lived experience into every stage to foster trust, enhance research outcomes, and inform future strategies for treatment and prevention @sirsofficial.bsky.social go.nature.com/4lIGYfu
Dr Jean Addington discusses the challenges and highlights the most important aspects of the selection and application of clinical assessment and outcome measures in the large multisite AMP®SCZ study investigating CHR go.nature.com/4cHoQ1r @sirsofficial.bsky.social vimeo.com/1040425281
Schizophrenia Interview with Dr. Addington
This is "Schizophrenia Interview with Dr. Addington" by SIRS on Vimeo, the home for high quality videos and the people who love them.
vimeo.com
April 21, 2025 at 6:16 PM
Dr Jean Addington discusses the challenges and highlights the most important aspects of the selection and application of clinical assessment and outcome measures in the large multisite AMP®SCZ study investigating CHR go.nature.com/4cHoQ1r @sirsofficial.bsky.social vimeo.com/1040425281
New pathways for preventing schizophrenia: public and private partners collaborate in the international Accelerating Medicines Partnership® Schizophrenia consortium @sirsofficial.bsky.social go.nature.com/3Y89zks
Pathways to prevention: the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) Program - Schizophrenia
Schizophrenia - Pathways to prevention: the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) Program
go.nature.com
April 20, 2025 at 12:03 PM
New pathways for preventing schizophrenia: public and private partners collaborate in the international Accelerating Medicines Partnership® Schizophrenia consortium @sirsofficial.bsky.social go.nature.com/3Y89zks
Reposted by Schizophrenia Journal
Our new paper titled "The MR #neuroimaging protocol for the Accelerating Medicines Partnership® #Schizophrenia Program" is now published in @schizjournal.bsky.social
www.nature.com/articles/s41...
www.nature.com/articles/s41...
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program - Schizophrenia
Schizophrenia - The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program
www.nature.com
April 5, 2025 at 8:15 PM
Our new paper titled "The MR #neuroimaging protocol for the Accelerating Medicines Partnership® #Schizophrenia Program" is now published in @schizjournal.bsky.social
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Schizophrenia Journal
Late highlight at #SIRS2025 @sirsofficial.bsky.social well worth staying for: symposium on cognitive impairments in psychosis, with chairs @rob-mccutcheon.bsky.social & Ingrid Melle (pic), and Sherry KW Chan, David Lewis, Richard Keefe - highlighting course, contributors, and ways forward.
April 2, 2025 at 5:31 PM
Late highlight at #SIRS2025 @sirsofficial.bsky.social well worth staying for: symposium on cognitive impairments in psychosis, with chairs @rob-mccutcheon.bsky.social & Ingrid Melle (pic), and Sherry KW Chan, David Lewis, Richard Keefe - highlighting course, contributors, and ways forward.
New paper revealing the intricate data operations behind the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) project, managing data across two research networks comprising 43 international sites
bit.ly/43NfHlS @sirsofficial.bsky.social
bit.ly/43NfHlS @sirsofficial.bsky.social
Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program - Schizophrenia
Schizophrenia - Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program
bit.ly
April 8, 2025 at 9:48 PM
New paper revealing the intricate data operations behind the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) project, managing data across two research networks comprising 43 international sites
bit.ly/43NfHlS @sirsofficial.bsky.social
bit.ly/43NfHlS @sirsofficial.bsky.social
Reposted by Schizophrenia Journal
Keynote on digital interventions for psychosis: Mario Alvarez-Jimenez kicking off day 3 @ #SIRS2025 @sirsofficial.bsky.social with powerful images on the omnipresence of technology in our daily lives - before elegantly demonstrating how this could be exploited to address current treatment challenges
March 31, 2025 at 2:32 PM
Keynote on digital interventions for psychosis: Mario Alvarez-Jimenez kicking off day 3 @ #SIRS2025 @sirsofficial.bsky.social with powerful images on the omnipresence of technology in our daily lives - before elegantly demonstrating how this could be exploited to address current treatment challenges
Reposted by Schizophrenia Journal
Great symposium on self-disorders in schizophrenia at #SIRS2025 (@sirsofficial.bsky.social), spearheaded by @jfeyaerts.bsky.social, with exciting empirical findings presented by @ccrosenphd.bsky.social (20-year follow-up!) and Julia Lebovitz, and a stimulating discussion by Louis Sass.
March 30, 2025 at 5:13 PM
Great symposium on self-disorders in schizophrenia at #SIRS2025 (@sirsofficial.bsky.social), spearheaded by @jfeyaerts.bsky.social, with exciting empirical findings presented by @ccrosenphd.bsky.social (20-year follow-up!) and Julia Lebovitz, and a stimulating discussion by Louis Sass.
Reposted by Schizophrenia Journal
Day two is here of #SIRS2025. We are still riding the wave from last night's keynote with Dr. Vikram Patel. Today, we continue to dive deeper into "Innovation Integration: Uniting Research and Practice in Schizophrenia."
Let's make this another memorable day!
Let's make this another memorable day!
March 30, 2025 at 12:53 PM
Day two is here of #SIRS2025. We are still riding the wave from last night's keynote with Dr. Vikram Patel. Today, we continue to dive deeper into "Innovation Integration: Uniting Research and Practice in Schizophrenia."
Let's make this another memorable day!
Let's make this another memorable day!
Reposted by Schizophrenia Journal
Don't miss today's Plenaries:
➡️ "Adolescent Stress as a Risk Factor for Schizophrenia: Insight from Animal Models" with Dr. Anthony Grace
🕘 9 AM - 10 AM
➡️ "Maintenance Treatment Strategies in Psychotic Disorders " with Dr. Christy Hui
🕘 2 PM - 3 PM 📍
➡️ "Adolescent Stress as a Risk Factor for Schizophrenia: Insight from Animal Models" with Dr. Anthony Grace
🕘 9 AM - 10 AM
➡️ "Maintenance Treatment Strategies in Psychotic Disorders " with Dr. Christy Hui
🕘 2 PM - 3 PM 📍
March 30, 2025 at 1:01 PM
Don't miss today's Plenaries:
➡️ "Adolescent Stress as a Risk Factor for Schizophrenia: Insight from Animal Models" with Dr. Anthony Grace
🕘 9 AM - 10 AM
➡️ "Maintenance Treatment Strategies in Psychotic Disorders " with Dr. Christy Hui
🕘 2 PM - 3 PM 📍
➡️ "Adolescent Stress as a Risk Factor for Schizophrenia: Insight from Animal Models" with Dr. Anthony Grace
🕘 9 AM - 10 AM
➡️ "Maintenance Treatment Strategies in Psychotic Disorders " with Dr. Christy Hui
🕘 2 PM - 3 PM 📍